Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non-Small-Cell Lung Cancer Article

ESI Most Cited Paper Industry Collaboration International Collaboration

cited authors

  • Solomon, Benjamin J.; Kim, Dong-Wan; Wu, Yi-Long; Nakagawa, Kazuhiko; Mekhail, Tarek; Felip, Enriqueta; Cappuzzo, Federico; Paolini, Jolanda; Usari, Tiziana; Tang, Yiyun; Wilner, Keith D.; Blackhall, Fiona; Mok, Tony S.

authors

Publication Date

  • August 1, 2018

webpage

published in

category

start page

  • 2251

end page

  • +

volume

  • 36

issue

  • 22